TY - JOUR
T1 - The potential of lung epithelium specific proteins as biomarkers for covid-19-associated lung injury
AU - Almuntashiri, Sultan
AU - James, Chelsea
AU - Wang, Xiaoyun
AU - Siddiqui, Budder
AU - Zhang, Duo
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/9
Y1 - 2021/9
N2 - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was first reported in Wuhan, China, and was declared a pandemic by the World Health Organization (WHO) on 20 March 2020. The respiratory system is the major organ system affected by COVID-19. Numerous studies have found lung abnormalities in patients with COVID-19, including shortness of breath, respiratory failure, and acute respiratory distress syndrome. The identification of lung-specific biomarkers that are easily measurable in serum would be valuable for both clinicians and patients with such conditions. This review is focused on the pneumoproteins and their potential to serve as biomarkers for COVID-19-associated lung injury, including Krebs von den Lungen-6 (KL-6), surfactant proteins (SP-A, SP-B, SP-C, SP-D), and Clara cell secretory protein (CC16). The current findings indicate the aforementioned pneumoproteins may reflect the severity of pulmonary manifestations and could serve as potential biomarkers in COVID-19-related lung injury.
AB - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was first reported in Wuhan, China, and was declared a pandemic by the World Health Organization (WHO) on 20 March 2020. The respiratory system is the major organ system affected by COVID-19. Numerous studies have found lung abnormalities in patients with COVID-19, including shortness of breath, respiratory failure, and acute respiratory distress syndrome. The identification of lung-specific biomarkers that are easily measurable in serum would be valuable for both clinicians and patients with such conditions. This review is focused on the pneumoproteins and their potential to serve as biomarkers for COVID-19-associated lung injury, including Krebs von den Lungen-6 (KL-6), surfactant proteins (SP-A, SP-B, SP-C, SP-D), and Clara cell secretory protein (CC16). The current findings indicate the aforementioned pneumoproteins may reflect the severity of pulmonary manifestations and could serve as potential biomarkers in COVID-19-related lung injury.
KW - CC16
KW - Epithelial cell
KW - Inflammation
KW - KL-6
KW - SARS-CoV
KW - SARS-CoV-2
KW - Surfactant proteins
UR - http://www.scopus.com/inward/record.url?scp=85116599523&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116599523&partnerID=8YFLogxK
U2 - 10.3390/DIAGNOSTICS11091643
DO - 10.3390/DIAGNOSTICS11091643
M3 - Review article
AN - SCOPUS:85116599523
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 9
M1 - 1643
ER -